UPDATE - UBS Initiates Coverage on Monsanto (MON) with a Neutral; Stock Valuation Stretched to the Limit
Tweet
Share
E-mailGet Alerts MON Hot Sheet
Price: $10.07 --0%
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 13 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS initiates coverage on Monsanto (NYSE: MON) with a Neutral. PT $72.00
UBS analyst says, "We expect Monsanto to book earnings growth of 20% in fiscal 2012 as its new suite of products for row crop growers continues to penetrate the market. Product attributes include higher yielding seeds, advanced insect protection, the elimination of some structural refuges, and more options for weed control."
"Even against big cap medical biotech companies, Monsanto’s recent price to estimated forward 12-months earnings ratio is 8.5 multiples higher, and Monsanto has a higher EV/EBITDA ratio as well. Monsanto’s stock price is at risk of losing value should the multiples contract, an increasing risk as the rate of earnings growth slows."
To see more ratings changes on MON, Click Here
UBS analyst says, "We expect Monsanto to book earnings growth of 20% in fiscal 2012 as its new suite of products for row crop growers continues to penetrate the market. Product attributes include higher yielding seeds, advanced insect protection, the elimination of some structural refuges, and more options for weed control."
"Even against big cap medical biotech companies, Monsanto’s recent price to estimated forward 12-months earnings ratio is 8.5 multiples higher, and Monsanto has a higher EV/EBITDA ratio as well. Monsanto’s stock price is at risk of losing value should the multiples contract, an increasing risk as the rate of earnings growth slows."
To see more ratings changes on MON, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBS, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
